Targeting NF-κB pathway for the therapy of diseases: mechanism and clinical study | Signal Transduction and Targeted Therapy
A novel player in inflammation and cancer: The deubiquitinase CYLD controls HCC development - Journal of Hepatology
NF-κB, inflammation, immunity and cancer: coming of age | Nature Reviews Immunology
Cancers | Free Full-Text | NF-κB Signaling in Ovarian Cancer
Catalpol synergistically potentiates the anti-tumour effects of regorafenib against hepatocellular carcinoma via dual inhibition of PI3K/Akt/mTOR/NF-κB and VEGF/VEGFR2 signaling pathways | SpringerLink
NF-κB in the liver—linking injury, fibrosis and hepatocellular carcinoma | Nature Reviews Gastroenterology & Hepatology
The Ras/MAPK pathway and hepatocarcinoma: pathogenesis and therapeutic implications - Delire - 2015 - European Journal of Clinical Investigation - Wiley Online Library
Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
Roles of MAP3Ks in controlling the function of stress-activated MAPK... | Download Scientific Diagram
MiR-1180 promotes apoptotic resistance to human hepatocellular carcinoma via activation of NF-κB signaling pathway | Scientific Reports
The Nuclear Factor Kappa-B Signaling Pathway as a Therapeutic Target Against Thyroid Cancers | Thyroid
The nuclear factor-kappa B pathway and response to treatment in breast cancer | Pharmacogenomics
A general overview of the three different signaling pathways... | Download Scientific Diagram
Hepatocellular carcinoma: Mechanisms of progression and immunotherapy
Cancers | Free Full-Text | MAPK/ERK Signaling Pathway in Hepatocellular Carcinoma
NF-κB signaling, liver disease and hepatoprotective agents | Oncogene
The complexity of NF-κB signaling in inflammation and cancer | Molecular Cancer | Full Text
Critical signaling pathways governing hepatocellular carcinoma behavior; small molecule-based approaches | Cancer Cell International | Full Text
Interplay between HBx protein and PTEN. (1) HBx mediates upregulation... | Download Scientific Diagram
Activation of the p38 MAPK/NF-κB pathway contributes to doxorubicin-induced inflammation and cytotoxicity in H9c2 cardiac cells
